-+ 0.00%
-+ 0.00%
-+ 0.00%

*Hoth Therapeutics Intends to Continue Its Biotechnology Programs, Exploring Placing Biotechnology Assets in a Separate, Wholly Owned Subsidiary >HOTH

Dow Jones·05/19/2026 12:19:00

Please log in to view news